FDA approves new Alzheimer’s PET imaging agent from Lantheus
FDA approves new Alzheimer’s PET imaging agent from Lantheus Radiology Business
2026
US FDA approves Lantheus’ brain-imaging agent for Alzheimer’s assessment
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment Reuters
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup NeurologyLive